SCHEMBL3222162

SCHEMBL3222162

O=C(c1ncccn1)c1oc2ccc(Cc3ccc(F)cc3)cc2c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.40
CNR2 P34972 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
NR3C2 P08235 1/20 0.34
KMT2A Q03164 1/20 0.34
GRM2 Q14416 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
NCOA1 Q15788 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
GPR52 Q9Y2T5 1/20 0.34
PARP1 P09874 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6768898 0.88 HSD17B14 (0.39) NQO1CNR2GPR55MAPTLMNA
SCHEMBL3220870 0.79 NQO1 (0.44) NQO1CNR2GPR55MAPTLMNA
SCHEMBL13456416 0.76 NQO1 (0.46) NQO1MAPTHTTKMT2ANPC1
SCHEMBL3220428 0.75 NQO1 (0.40) NQO1CNR2GPR55MAPTLMNA
SCHEMBL6720338 0.74 NQO1 (0.53) NQO1CNR2GPR55LMNAHTT
SCHEMBL13255593 0.69 PARP1 (0.40) LMNAKMT2ANPC1RAB9APARP1
SCHEMBL6720324 0.66 NQO1 (0.52) NQO1GPR55LMNAHTTKMT2A
SCHEMBL3221505 0.65 LMNA (0.60) LMNAHTTKMT2A
SCHEMBL6720350 0.65 GPR55 (0.43) NQO1GPR55LMNA
SCHEMBL755830 0.65 MAPT (0.43) NQO1MAPTLMNAKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100068695-A1 Inhibitor for enzyme having two divalent metal ions as active center KIYAMA RYUICHI 2010-03-18 US disclosed
US-20100068695-A1 Inhibitor for enzyme having two divalent metal ions as active center KIYAMA RYUICHI 2010-03-18 US disclosed
US-20100068695-A1 Inhibitor for enzyme having two divalent metal ions as active center KIYAMA RYUICHI 2010-03-18 US disclosed
US-20040039060-A1 Inhibitor for enzyme having two divalent metal ions as active centers SHIONOGI & CO., LTD. (JP) 2004-02-26 US disclosed
EP-1297834-A1 INHIBITOR FOR ENZYME HAVING TWO DIVALENT METAL IONS AS ACTIVE CENTERS SHIONOGI & CO., LTD. (JP) 2003-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039060-A1 Inhibitor for enzyme having two divalent metal ions as active centers GAA, CMA1, MMEL1 NQO1 633/4885CNR2 4745/4885GPR55 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.